CLLS240719P2500
- 0.45
- 0.000.00%
Cellectis Newsroom
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4%
European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading
Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)
Monthly Information on Share Capital and Company Voting Rights
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
Cellectis | 6-K: Report of foreign private issuer (related to financial reporting)
Press Release: Cellectis Reports Results From Shareholders Meeting Held on June 28, 2024
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher
Express News | Cellectis Publishes Scientific Article Demonstrating Three Key Factors For Efficient TALE Base Editing
Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading
Cellectis (CLLS) Upgraded to Buy: Here's Why
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading
Bank Stocks Help Nudge European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
European Equities Traded in the US as American Depositary Receipts Sharply Lower in Thursday Trading
Express News | Cellectis Reports Publication Of A Scientific Article In Nature Communications, Unveiling Non-viral Gene Therapy Approach For Sickle Cell Disease